M&T Bank’s Pfizer PFE Stock Holding History

M&T Bank’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$74.7M	Buy	2,660,449 +120,908	+5%	+$3.22M	0.26%	86
2025 Q4	$63.2M	Buy	2,539,541 +183,931	+8%	+$4.64M	0.2%	91
2025 Q3	$60M	Sell	2,355,610 -213,358	-8%	-$5.27M	0.2%	92
2025 Q2	$62.3M	Buy	2,568,968 +40,612	+2%	+$947K	0.21%	91
2025 Q1	$64.1M	Buy	2,528,356 +31,535	+1%	+$825K	0.23%	87
2024 Q4	$66.2M	Sell	2,496,821 -393,230	-14%	-$10.7M	0.22%	88
2024 Q3	$83.6M	Buy	2,890,051 +148,022	+5%	+$4.32M	0.28%	78
2024 Q2	$76.7M	Buy	2,742,029 +48,265	+2%	+$1.33M	0.26%	78
2024 Q1	$74.8M	Buy	2,693,764 +139,566	+5%	+$3.87M	0.26%	86
2023 Q4	$73.5M	Sell	2,554,198 -280,140	-10%	-$8.47M	0.27%	85
2023 Q3	$94M	Sell	2,834,338 -86,968	-3%	-$3.08M	0.38%	63
2023 Q2	$107M	Sell	2,921,306 -45,455	-2%	-$1.77M	0.4%	56
2023 Q1	$121M	Sell	2,966,761 -31,418	-1%	-$1.36M	0.47%	46
2022 Q4	$154M	Sell	2,998,179 -4,622	-0.2%	-$222K	0.62%	31
2022 Q3	$131M	Buy	3,002,801 +50,463	+2%	+$2.45M	0.58%	39
2022 Q2	$144M	Buy	2,952,338 +248,594	+9%	+$12.7M	0.68%	30
2022 Q1	$140M	Sell	2,703,744 -49,146	-2%	-$2.55M	0.62%	36
2021 Q4	$163M	Sell	2,752,890 -82,748	-3%	-$4.1M	0.68%	27
2021 Q3	$122M	Sell	2,835,638 -24,239	-0.8%	-$1.07M	0.55%	41
2021 Q2	$112M	Sell	2,859,877 -149,162	-5%	-$5.8M	0.49%	44
2021 Q1	$109M	Sell	3,009,039 -141,902	-5%	-$5.04M	0.47%	43
2020 Q4	$116M	Sell	3,150,941 -236,838	-7%	-$8.69M	0.51%	42
2020 Q3	$118M	Sell	3,387,779 -362,631	-10%	-$12.7M	0.58%	37
2020 Q2	$116M	Sell	3,750,410 -80,155	-2%	-$2.72M	0.62%	37
2020 Q1	$119M	Sell	3,830,565 -67,128	-2%	-$2.29M	0.7%	28
2019 Q4	$145M	Sell	3,897,693 -19,023	-0.5%	-$678K	0.68%	28
2019 Q3	$134M	Sell	3,916,716 -7,060	-0.2%	-$257K	0.67%	38
2019 Q2	$161M	Sell	3,923,776 -85,799	-2%	-$3.41M	0.84%	27
2019 Q1	$162M	Sell	4,009,575 -42,487	-1%	-$1.7M	0.84%	27
2018 Q4	$168M	Sell	4,052,062 -67,074	-2%	-$2.78M	0.96%	23
2018 Q3	$172M	Sell	4,119,136 -88,661	-2%	-$3.41M	0.86%	23
2018 Q2	$145M	Buy	4,207,797 +10,051	+0.2%	+$343K	0.78%	26
2018 Q1	$141M	Sell	4,197,746 -27,455	-0.6%	-$944K	0.76%	29
2017 Q4	$145M	Sell	4,225,201 -7,753	-0.2%	-$264K	0.76%	30
2017 Q3	$143M	Buy	4,232,954 +42,048	+1%	+$1.35M	0.78%	27
2017 Q2	$134M	Sell	4,190,906 -92,297	-2%	-$2.91M	0.79%	29
2017 Q1	$139M	Buy	4,283,203 +218,395	+5%	+$6.89M	0.84%	28
2016 Q4	$125M	Buy	4,064,808 +97,895	+2%	+$2.99M	0.78%	30
2016 Q3	$127M	Sell	3,966,913 -119,192	-3%	-$3.99M	0.81%	27
2016 Q2	$137M	Sell	4,086,105 -78,478	-2%	-$2.5M	0.92%	21
2016 Q1	$117M	Buy	4,164,583 +20,731	+0.5%	+$592K	0.79%	26
2015 Q4	$127M	Sell	4,143,852 -1,477	-0%	-$46.5K	0.84%	24
2015 Q3	$124M	Buy	4,145,329 +512,290	+14%	+$16.4M	0.84%	25
2015 Q2	$116M	Sell	3,633,039 -51,604	-1%	-$1.68M	0.7%	30
2015 Q1	$122M	Sell	3,684,643 -31,551	-0.8%	-$1M	0.76%	26
2014 Q4	$110M	Buy	3,716,194 +40,493	+1%	+$1.16M	0.69%	25
2014 Q3	$103M	Buy	3,675,701 +2,773,784	+308%	+$77.8M	0.66%	27
2014 Q2	$25.4M	Sell	901,917 -195,462	-18%	-$5.57M	1.06%	16
2014 Q1	$33.4M	Sell	1,097,379 -8,759	-0.8%	-$261K	1.39%	12
2013 Q4	$32.1M	Sell	1,106,138 -10,850	-1%	-$316K	1.35%	13
2013 Q3	$30.4M	Sell	1,116,988 -35,244	-3%	-$959K	1.45%	13
2013 Q2	$30.6M	Buy	+1,152,232	New	+$31.8M	1.48%	12

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

M&T Bank's PFE Position: Q1 2026 in Review

M&T Bank increased its Pfizer (PFE) stake by 4.8% in Q1 2026, buying an estimated $3.22M and bringing the position to 2,660,449 shares worth $74.7M. The position accounts for 0.26% of the portfolio, ranked #86.

M&T Bank first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $172M in Q3 2018. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

M&T Bank held 2,660,449 shares of Pfizer worth $74.7M as of Q1 2026.
M&T Bank bought 120,908 Pfizer shares in Q1 2026, an estimated $3.22M.
Pfizer made up 0.26% of M&T Bank's portfolio in Q1 2026, its #86 holding.
M&T Bank first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
M&T Bank's Pfizer position peaked at $172M in Q3 2018.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.